1. Ampelopsin targets in cellular processes of cancer: Recent trends and advances
   Hardeep Singh Tuli et al, 2022, Toxicology Reports CrossRef
2. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition
   Lei Shao et al, 2017, Biochemical and Biophysical Research Communications CrossRef
3. Ampelopsin suppresses TNF-α-induced migration and invasion of U2OS osteosarcoma cells
   CHANGYING LIU et al, 2016, Molecular Medicine Reports CrossRef
4. Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review)
   Tian Xia et al, 2024, Biomedical Reports CrossRef
5. A comprehensive review of vine tea: Origin, research on Materia Medica, phytochemistry and pharmacology
   Tiexin Zeng et al, 2023, Journal of Ethnopharmacology CrossRef
6. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer
   Jiajun Wu et al, 2022, Cancers CrossRef
7. Mechanism of Ampelopsin Inhibiting Proliferation, Remove and Incursion of Colorectal Cancer Through Regulating the Expression of LncRNA ZFPM2-AS1/miR-515-5p
   Sheng Yuan et al, 2021, Journal of Biomaterials and Tissue Engineering CrossRef
8. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease
   Jingnan Chen et al, 2021, Biomedicine & Pharmacotherapy CrossRef
9. Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
   Zhonghe Zhao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
10. In vitro efficacy of ampelopsin against Echinococcus granulosus and Echinococcus multilocularis
    Qi XIN et al, 2019, Journal of Veterinary Medical Science CrossRef
11. The Inhibition of Cell Growth Through the EGFR/ERK/MMP-2 Pathway Induced by Ampelopsin in the Human Malignant Melanoma A375 Cell Line
    Fan Yang et al, 2020, Natural Product Communications CrossRef
12. OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer
    Zhong Yu et al, 2023, Discover Oncology CrossRef
13. Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231
    Francis Yew Fu Tieng et al, 2019, Molecules CrossRef
14. Ampelopsin‑sodium induces apoptosis in human lung adenocarcinoma cell lines by promoting tubulin polymerization in�vitro
    Lijuan Zhu et al, 2019, Oncology Letters CrossRef
15. Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway
    Tong Guo et al, 2023, Frontiers in Oncology CrossRef
16. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis
    Hongjuan You et al, 2021, Cell Communication and Signaling CrossRef
17. Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway
    Seung-Woo Hong et al, 2017, Lung Cancer CrossRef
18. Purification and thermochemical properties of dihydromyricetin
    Yan-Bin Meng et al, 2016, Journal of Thermal Analysis and Calorimetry CrossRef
19. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
    Sajad Fakhri et al, 2024, Cancer and Metastasis Reviews CrossRef